Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Irina V.
Irina V. Balyasnikova, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110129414 | Single Chain Fragment of Monoclonal Antibody 9B9 and Uses Thereof - Anti-ACE single chain fragment antibodies are disclosed. The present invention relates to using these antibodies, and polymers thereof, in methods for detecting, diagnosing, prognosing, preventing, or treating diseases associated with ACE expressing tissue. | 06-02-2011 |
Irina V. Guzhova, St-Petersburg RU
| Patent application number | Description | Published |
|---|---|---|
| 20110059116 | LASER-BASED VACCINE ADJUVANTS - The invention is directed to a vaccine for generating an enhanced immune response in a subject previously exposed to non-destructive laser radiation, as compared to an immune response in a subject previously non-exposed to non-destructive laser radiation. The invention is also directed to use of a composition comprising a vaccine for use in combination with non-destructive laser radiation for generating an enhanced immune response from a subject, as compared to an immune response without the use of laser radiation. The laser exposure acts as an adjuvant for the vaccine, increasing the efficacy and/or potency of the vaccine. | 03-10-2011 |
Irina V. Khanskaya, Morristown, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110009482 | METHODS OF TREATING COPD - Disclosed is a method of treating chronic obstructive disease, said method comprising administering an effective amount of a CXCR2 antagonist and administering an effective amount of at least one drug selected from the group consisting of: angiotensin-converting enzyme inhibitors, Angiotensin II receptor antagonists, cardioselective beta blockers, and lipid regulating drugs. Examples of the CXCR2 antagonist include: (formula 1.0A and 1.0B). | 01-13-2011 |
Irina V. Klimanskaya, Upton, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110117062 | Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells - This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells. | 05-19-2011 |
| 20110117063 | Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells For Treatment of Retinal Degeneration - This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells. | 05-19-2011 |
Irina V. Lebedeva, Bronx, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100081159 | Profiling reactive oxygen, nitrogen and halogen species - This invention provides methods, kits and systems which permit simultaneous profiling of multiple reactive oxygen species (ROS), reactive nitrogen species (RNS) and/or reactive halogen species (RHS) including reactive chlorine species (RCS) and/or reactive bromine species (RBS) through multiplexed fluorescence detection of three or more indicator probes in live cells or subcellular organelles. | 04-01-2010 |